[1] Ramani S,Atmar RL,Estes MK.Epidemiology of human noroviruses and updates on vaccine development[J].Current Opinion in Gastroenterology,2014,30(1):25-33. [2] Lopman B,Gastanaduy P,Park GW,et al.Environmental transmission of norovirus gastroenteritis[J].Current opinion in virology,2012,2(1):96-102. [3] Scallan E,Hoekstra RM,Angulo FJ,et al.Foodborne illness acquired in the United States-major pathogens[J].Emerging Infectious Diseases,2011,17(1):7-15. [4] Payne DC,Vinje J,Szilagyi PG,et al.Norovirus and medically attended gastroenteritis in U.S.children[J].The New England Journal of Medicine,2013,368(12):1121-1130. [5] Thorne LG,Goodfellow IG.Norovirus gene expression and replication[J].The Journal of General Virology,2014,95(Pt 2):278-291. [6] Robilotti E,Deresinski S,Pinsky BA.Norovirus[J].Clinical Microbiology Reviews,2015,28(1):134-164. [7] Donaldson EF,Lindesmith LC,Lobue AD,et al.Viral shape-shifting:norovirus evasion of the human immune system[J].Nature Reviews Microbiology,2010,8(3):231-241. [8] Chan-it W,Thongprachum A,Okitsu S,et al.Genetic analysis and homology modeling of capsid protein of norovirus GII.14[J].Journal of Medical Virology,2014,86(2):329-334. [9] Sabria A,Pinto RM,Bosch A,et al.Molecular and clinical epidemiology of norovirus outbreaks in Spain during the emergence of GII.4 2012 variant[J].Journal of Clinical Virology :the Official Publication of the Pan American Society for Clinical Virology,2014,60(2):96-104. [10] Bok K,Green KY.Norovirus gastroenteritis in immunocompromised patients[J].The New England Journal of Medicine,2012,367(22):2126-2132. [11] Seitz SR,Leon JS,Schwab KJ,et al.Norovirus infectivity in humans and persistence in water[J].Applied and Environ Mental Microbiology,2011,77(19):6884-6888. [12] Division of Viral Diseases NCFI,Respiratory Diseases CFDC,Prevention.Updated norovirus outbreak management and disease prevention guidelines[J].MMWR Recommendations and Reports :Morbidity and Mortality Weekly Report Recommendations and Reports / Centers for Disease Control,2011,60(RR-3):1-18. [13] Marques Mendanha De Oliveira D,Souza M,Souza Fiaccadori F,et al.Monitoring of Calicivirus among day-care children:evidence of asymptomatic viral excretion and first report of GI.7 Norovirus and GI.3 Sapovirus in Brazil[J].Journal of Medical Virology,2014,86(9):1569-1575. [14] Lee RM,Lessler J,Lee RA,et al.Incubation periods of viral gastroenteritis:a systematic review[J].BMC Infectious Diseases,2013,13:446. [15] Claas EC,Burnham CA,Mazzulli T,et al.Performance of the xTAG(R) gastrointestinal pathogen panel,a multiplex molecular assay for simultaneous detection of bacterial,viral,and parasitic causes of infectious gastroenteritis[J].Journal of Microbiology and Biotechnology,2013,23(7):1041-1045. [16] Wessels E,Rusman LG,Van Bussel MJ,et al.Added value of multiplex Luminex Gastrointestinal Pathogen Panel (xTAG(R) GPP) testing in the diagnosis of infectious gastroenteritis[J].Clinical Microbiology and Infection:the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases,2014,20(3):182-187. [17] Greig JD,Lee MB.A review of nosocomial norovirus outbreaks:infection control interventions found effective[J].Epidemiology and Infection,2012,140(7):1151-1160. [18] Maccannell T,Umscheid CA,Agarwal RK,et al.Guideline for the prevention and control of norovirus gastroenteritis outbreaks in healthcare settings[J].Infection Control and Hospital Epidemiology,2011,32(10):939-969. [19] Bartsch SM,Lopman BA,Hall AJ,et al.The potential economic value of a human norovirus vaccine for the United States[J].Vaccine,2012,30(49):7097-7104. [20] Bernstein DI,Atmar RL,Lyon GM,et al.Norovirus vaccine against experimental human GII.4 virus illness:a challenge study in healthy adults[J].The Journal of Infectious Diseases,2015,211(6):870-878. [21] Wang L,Cao D,Wei C,et al.A dual vaccine candidate against norovirus and hepatitis E virus[J].Vaccine,2014,32(4):445-452. [22] Roldao A,Mellado MC,Castilho LR,et al.Virus-like particles in vaccine development[J].Expert Review of Vaccines,2010,9(10):1149-1176.
PDF(454 KB)
